Evaluation of remifentanil in endoscopic retrograde cholangio- pancreatography

Middle East Journal of Anesthesiology

Volumn 18, Issue 6, 2006, Pages 1209-1216

  El Bitar, N ^a   Sfeir, S ^a  

^a UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

Cholangio pancreatography; Conscious sedation; Endoscopic Retrograde; Remifentanil

Indexed keywords

FENTANYL; INTRAVENOUS ANESTHETIC AGENT; MIDAZOLAM; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE; REMIFENTANIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSCIOUS SEDATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANESTHETICS, INTRAVENOUS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONSCIOUS SEDATION; FEMALE; FENTANYL; HUMANS; MALE; MIDAZOLAM; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PIPERIDINES; STATISTICS;

EID: 33846120950     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. FELDMAN PL, JAMES MK, BRACKEEN MF, ET AL: Design synthesis and pharmacological evaluation of ultrashort - to long-acting opioid analgesics. J Med Chem; 34:1102-8, 1991.
2. WESTMORELAND CL, HOKE JF, SEBEL PS, HUG CC, MUIR KT: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology; 79:893-903, 1993.
3. EGAN TD, HUIZINGA B, GUPTA SK, ET AL: Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology; 89:562-73, 1998.
4. DERSHWITZ M, HOKE JF, ROSOW CE, MICHALOWSKI P, CONNORS PM, MUIR KT, DIENSTAG JL: Pharmacokinetics and pharamcodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology; 84(4):812-20, Apr, 1996.
5. GLASS PS, HARDMAN D, KAMIYAMA Y, ET AL: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg; 77:31-40, 1993.
6. EGAN TD, LEMMENS HF, FISET P, ET AL: The pharmacokinetics of the new short-acting remifentanil in healthy adult male volunteers. Anesthesiology; 79:881-92, 1993.
7. HOKE JF, SHULGMAN D, DERSHWITZ M, ET AL: Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology; 87:533-41, 1997.
8. CUNNINGHAM FE, HOKE JF, MUIR KT, JAMES MK, HOFFMAN WE: Pharmacokinetic/pharmacodynamic evaluation of remifentanil, GR90291, and alfentanil. Anesthesiology; 83:A376, 1995.
9. NOSEIR RK, FICKE DJ, KUNDU A, ARAIN SR, EBERT TJ: Sympathetic and vascular consequences from remifentanil in humans. Anesthesia & Analgesia; 96(6):1645-50, table of contents, Jun, 2003.
10. SAHEL J, BARTHET M, GASMI M: The substitution of endoscopic ultrasonography for endoscopic retrograde cholangio- pancreatography: implications for service development and training. European Journal of Gastroenterology & Hepatology; 16(3):291-4, Mar, 2004.